Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class ASSE: 600436

Announcement on Convening Performance Briefing for 2025 and Q1 2026

· Issued by Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening Performance Briefing for 2025 and Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment